This is a preview of subscription content, log in via an institution to check access.
Notes
Commercial Claims and Encounters
The study and article publication charges were funded by Otsuka America Pharmaceutical, Inc. and H. Lundbeck A/S.
Reference
Offord S, et al. Impact of Early Nonadherence to Oral Antipsychotics on Clinical and Economic Outcomes Among Patients with Schizophrenia. Advances in Therapy : 8 Mar 2013. Available from: URL: http://dx.doi.org/10.1007/s12325-013-0016-5
Rights and permissions
About this article
Cite this article
Early non-adherence to antipsychotics incurs higher costs. PharmacoEcon Outcomes News 675, 7 (2013). https://doi.org/10.1007/s40274-013-0284-y
Published:
Issue Date:
DOI: https://doi.org/10.1007/s40274-013-0284-y